MaaT Pharma S.A.: MaaT Pharma Announces the Partial Exercise of the Over-Allotment Option and the Total Size of the Offering at Approximately €35.7m

Partial exercise of the Over-Allotment Option through the issuance of 314,055 new shares, amounting to approximately €4.2m Definitive size of the offering increased to approximately €35.7m Regulatory

Related Keywords

South Africa ,Australia ,Japan ,United States ,Canada ,United Kingdom ,France ,America ,French ,Tony Garnier ,Financial Press Relations ,Registration Document Of The Company ,European Parliament ,United Kingdom Financial Conduct Authority ,Financial Services ,Trophic Communications ,Corporate Communications ,European Union Withdrawal ,Commission Delegated Directive ,Over Allotment Option ,Euronext Paris ,Joint Global Coordinator ,Joint Bookrunner ,Maat Pharma ,Mutuel Innovation ,Registration Document ,Security Notes ,Microbiome Ecosystem Therapies ,Securities Act ,Member States ,European Economic Area ,Prospectus Regulation ,French Autorit ,Markets Act ,Prospectus Rules ,European Union ,Financial Promotion ,Market Act ,Relevant Person ,Governance Requirements ,Offered Shares ,Target Market Assessment ,Communications Manager ,Financial Communication ,Jamaat ,Dharma ,Nnounces ,Artial ,Exercise ,Dover ,Allotment ,Option ,Total ,Size ,Offering ,Pproximately ,